Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnendu Pal

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Research Square|November 24, 2025
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiformeRamcharan Singh Angom, Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al.
Communications Medicine|March 19, 2026
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiformeRamcharan Singh Angom, Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al.
Molecular Cancer Therapeutics|October 3, 2019
Molecular Inhibitor of QSOX1 Suppresses Tumor Growth <i>In Vivo</i>Amber L Fifield, Paul D Hanavan, Douglas O Faigel, et al.
Nucleic Acids Research|September 25, 2014
Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculinRam Krishna Thakur, Vinod Kumar Yadav, Akinchan Kumar, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Research Square|November 24, 2025
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiformeRamcharan Singh Angom, Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al.
Communications Medicine|March 19, 2026
Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiformeRamcharan Singh Angom, Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, et al.
Molecular Cancer Therapeutics|October 3, 2019
Molecular Inhibitor of QSOX1 Suppresses Tumor Growth <i>In Vivo</i>Amber L Fifield, Paul D Hanavan, Douglas O Faigel, et al.
Nucleic Acids Research|September 25, 2014
Non-metastatic 2 (NME2)-mediated suppression of lung cancer metastasis involves transcriptional regulation of key cell adhesion factor vinculinRam Krishna Thakur, Vinod Kumar Yadav, Akinchan Kumar, et al.
Pageof 5